Bladder cancer: open trials in Taiwan

15 open trials have a site in Taiwan. Registry data; only the trial team decides who can take part.

NCT07566156
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Trial Treatment · Phase 3 · Astellas Pharma Global Development, Inc.
Kaohsiung City
Registry updated 2026-10-28
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · Koo Foundation Sun Yat-Sen Cancer Center, Taipei · MacKay Memorial Hospital, Taipei · Chang Gung Memorial Hospital, Taoyuan
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
China Medical University Hospital, Taichung · National Cheng Kung University Hospitalx, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · Tri-Service General Hospital, Taipei · Koo Foundation Sun Yat-Sen Cancer Center, Taipei
Registry updated 2026-10-26
NCT07218380
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Trial Treatment · Phase 3 · Eli Lilly and Company
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist · Taichung Veterans General Hospital, Taichung · China Medical University Hospital, Taichung · Chi Mei Hospital - Liouying Branch, Tainan · Chi Mei Medical Center, Tainan · National Cheng Kung University Hospital, Tainan · National Taiwan University Cancer Center (NTUCC), Taipei · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · Chang Gung Medical Foundation-Linkou Branch, Taoyuan
Registry updated 2026-10-07
NCT05739071
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
Trial Treatment · Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Buddhist Tzu Chi General Hospital, Taipei branch, Taipei
Registry updated 2026-10-05
NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Trial Treatment · Phase 2 · Protara Therapeutics
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Registry updated 2026-08-24
NCT04752722
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Trial Treatment · Phase 1/2 · enGene, Inc.
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · China Medical University Hospital, Taichung · Chi Mei Medical Center, Tainan · National Taiwan University Hospital, Taipei
Registry updated 2026-08-07
NCT04198766
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Trial Treatment · Phase 1/2 · Inhibrx Biosciences, Inc
Changhua Christian Hospital (CCH), Changhua · E-Da Cancer Hospital, Kaohsiung City · Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), Kaohsiung City · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei
Registry updated 2026-07-29
NCT07720284
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Trial Treatment · Phase 3 · AstraZeneca
Kaohsiung City · Tainan · Taipei · Taoyuan
Registry updated 2026-07-22
NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Trial Treatment · Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
Kaohsiung Medical University Hospital, Kaohsiung City · National Taiwan University Hospital, Taipei · Taipei Veterans General Hospital, Taipei
Registry updated 2026-07-06
NCT07169734
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Trial Treatment · Phase 1/2 · Alentis Therapeutics AG
National Cheng Kung University Hospital, Tainan · National Taiwan University Hospital, Taipei · Chang Gung Medical Foundation - LinKou Chang Gung Memorial Hospital - Oncology, Taoyuan
Registry updated 2026-07-02
NCT07072637
Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based Therapy
Research · National Taiwan University Hospital
National Taiwan University Hospital, Taipei
Registry updated 2025-07-18
NCT06982690
Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial
Trial Treatment · National Taiwan University Hospital
Department of Urology, College of Medicine, National Taiwan University, Taipei
Registry updated 2025-05-21
NCT05739968
Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
Trial Treatment · National Taiwan University Hospital
National Taiwan University Hospital, Taipei
Registry updated 2024-06-05
NCT04641936
Urine Omics Predicting IO Therapy Responses in mUC Patients
Research · National Taiwan University Hospital
National Taiwan University Hospital, Taipei
Registry updated 2024-04-17

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error